Research Grants show all

NIH1

Publications show all

Ascenta Therapeutics has published 4 articles.

Patents show all

12Applications8Issued

Clinical Trials show all

6Phase 24Phase 1/Phase 22Phase 1

SEC Filings show all

D1

SEC Form D Funding Events

DateOfferedSoldType
2010-02-05$15,001,500$1,800,180Debt, Option to Acquire

Key Executives

  • J. Mel Sorensen
    Executive Officer, Director
  • Louis Bock
    Director
  • Michael Powell
    Executive Officer, Director
  • Marc Lippman
    Director
  • Joel Sussman
    Executive Officer, Director
  • Norman Selby
    Director
  • Andrew E. Senyei
    Director
  • Eckard Weber
    Director